Increased Disease Burden in Irritable Bowel Syndrome With Comorbid Conditions and Psychiatric Diagnoses in a Multinational European Cohort: Results From the DISCOvERIE Project
United European Gastroenterology Journal · 2026-02 · 14 (1)
DOI: 10.1002/ueg2.70157 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift United European Gastroenterology Journal, online erschienen am 24.12.2025. Verfasst von Irina Midenfjord und 25 weiteren Autor:innen. Beteiligte Einrichtung: University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Fibromyalgia, Cost of Illness, Depression. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Horizon 2020 Framework Program, Horizon 2020 Framework Programme.
Abstract (Originalsprache)
Background
Patients with Irritable bowel syndrome (IBS) frequently suffer from comorbid psychiatric or somatic conditions, but the association with overall GI symptom severity and disease burden in IBS has not yet been established.
Objective
This pan‐European project, the DISCOvERIE project, aimed to characterize IBS patients with and without comorbid psychiatric (anxiety, depression) and/or somatic (fibromyalgia, chronic fatigue syndrome) conditions, and to compare them with disease (psychiatric and/or somatic condition without IBS) and healthy controls to further elucidate the effect of comorbid conditions on the disease burden in IBS.
Methods
Participants from nine different European centers were included: IBS patients (Rome IV criteria) with and without comorbid conditions, disease controls, and healthy controls. The presence of comorbidities was assessed through the Mini International Neuropsychiatric Interview (MINI) for anxiety or depression or through diagnostic criteria for fibromyalgia or chronic fatigue syndrome. Validated questionnaires on IBS (IBS‐SSS), depressive (PHQ‐9), anxiety (GAD‐7) and somatic symptom severity (PHQ‐12), fibromyalgia symptoms (FIQ) and fatigue (MFI) were completed.
Results
In total, 842 participants were recruited between March 2021 and January 2023, of which 607 had IBS, 161 were disease controls and 74 were healthy controls. IBS, anxiety, depression, somatic symptoms and fatigue were more severe in IBS patients with comorbidities compared with IBS patients without comorbidities. The severity of the abovementioned symptoms all increased gradually with increasing number of comorbidities (all p < 0.001).
Conclusion
This large pan‐European study highlights the significant impact of psychiatric and somatic comorbidities in IBS, and their strong link with outcomes and disease burden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Gothenburg, Gothenburg, Sweden.
- Laboratory of Neuro-Immuno-Gastroenterology, Digestive System Research Unit, Vall d'Hebron Institut de Recerca (VHIR) and Department of Gastroenterology, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hosp…
- Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Nijmegen, the Netherlands.
- Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital, Goethe University, Frankfurt, Germany.
- Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main, Germany.
- Department of Chronic Diseases and Metabolism, Laboratory for Brain-Gut Axis Studies (LABGAS), Translational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium.
ORCID-Profile: Irina Midenfjord, Elias Sundelin, Hans Törnblom, Danique Mulder, Andreas Reif, Mareike Aichholzer, Lukas Van Oudenhove, Giovanni Barbara, Michelle Bosman, Josep Antoni Ramos-Quiroga, István Bitter, Andrei-Vasile Pop
Förderung
- Horizon 2020 Framework Program
- Horizon 2020 Framework Programme
Zitieren
APA
Midenfjord, I., Khadija, M., Sundelin, E., Trindade, I. A., Törnblom, H., Santos, J., Lobo, B., Mulder, D., Vasquez, A. A., Ruesing, G., Reif, A., Aichholzer, M., Van Den Houte, M., Van Oudenhove, L., Matteucci, M. C., Barbara, G., Bosman, M., Jonkers, D., Ramos-Quiroga, J. A., …, & Simrén, M. (2026). Increased Disease Burden in Irritable Bowel Syndrome With Comorbid Conditions and Psychiatric Diagnoses in a Multinational European Cohort: Results From the DISCOvERIE Project. United European Gastroenterology Journal, 14(1). https://doi.org/10.1002/ueg2.70157
Vancouver
Midenfjord I, Khadija M, Sundelin E, Trindade IA, Törnblom H, Santos J, et al. Increased Disease Burden in Irritable Bowel Syndrome With Comorbid Conditions and Psychiatric Diagnoses in a Multinational European Cohort: Results From the DISCOvERIE Project. United European Gastroenterology Journal. 2026;14(1). doi:10.1002/ueg2.70157
BibTeX
@article{Midenfjord2026,
author = {Midenfjord, Irina and Khadija, Mahrukh and Sundelin, Elias and Trindade, Inês A and Törnblom, Hans and Santos, Javier and Lobo, Beatriz and Mulder, Danique and Vasquez, Alejandro Arias and Ruesing, Georgy and Reif, Andreas and Aichholzer, Mareike and Van Den Houte, Maaike and Van Oudenhove, Lukas and Matteucci, Maria Chiara and Barbara, Giovanni and Bosman, Michelle and Jonkers, Daisy and Ramos-Quiroga, Josep Antoni and Jekkel, Eva and Bitter, István and Pop, Andrei-Vasile and Dumitrascu, Dan Lucian and Alonso-Cotoner, Carmen and Rodríguez-Urrutia, Amanda and Simrén, Magnus},
title = {Increased Disease Burden in Irritable Bowel Syndrome With Comorbid Conditions and Psychiatric Diagnoses in a Multinational European Cohort: Results From the DISCOvERIE Project},
journal = {United European Gastroenterology Journal},
year = {2026},
volume = {14},
number = {1},
doi = {10.1002/ueg2.70157}
}
EUVIMED